AstraZeneca’s IL‑33 biologic Tozorakimab hits multiple Phase III successes – Meet them this September

Altesa BioSciences advances Vapendavir for rhinovirus‑triggered COPD exacerbations

GSK expands its COPD pipeline with a novel siRNA therapy (EMP‑012)

Emerging COPD treatments highlight biologics, bronchoscopic procedures & stem‑cell approaches

ReAlta’s pegtarazimod showing early promise for acute COPD exacerbations in phase 2

GSK’s Nucala gains UK backing, expanding COPD biologic access with NICE recommendation

Windward Bio and Harbour Biomed announce first Phase II dosing in SIRIUS trial for novel COPD antibody therapy

TidalSense secured $19 million to commercialise its AI-powered COPD diagnostic technology

Day

Hour

Minute

Second

Raul San Jose Estepar

Director, Applied Chest Imaging Laboratory, Lead Investigator, Brigham & Women’s Hospital, Associate Professor Boston Children's Hospital

Tuesday 15th September 2026

Leveraging Digital Twins & Spatial Transcriptomics to Transform Modelling in Chronic Lung Disease

11:30 am

Understand how digital twins can reconstruct disease progression from static tissue samples to enable deeper mechanistic insights with spatial transcriptomics and early discovery research
Learn how integrating imaging data with multiomics enables more predictive and human-relevant preclinical models that better reflect disease heterogeneity and progression
Explore how digital twin approaches can bridge the gap between discovery and clinical translation by improving patient stratification and informing more predictive model systems